Top Markets
Coin of the day
Ainos, Inc. Ainos, Inc.

Ainos, Inc.

AIMD
Rank in Stocks #32145
Ainos, Inc. operates as a healthcare technology company, specializing in... Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.
Share Price
$1.49
Last synced: 2026-08-17
Market Cap
$10.94M
Change (1 day)
4.58%
Change (1 year)
-55.67%
Country
US
Trade Ainos, Inc. (AIMD)

Category

Dividend yield history for Ainos, Inc. (AIMD)
Ainos, Inc. (stock symbol: AIMD) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for Ainos, Inc. (AIMD) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors